CLINICAL TRIAL: ADJUNCTIVE TREATMENT WITH DIVALPROEX OR RISPERIDONE IN CHILDREN

临床试验：双丙戊酸钠或利培酮对儿童的辅助治疗

• 批准号: 8167261
• 负责人: Joseph C Blader
• 金额: $ 5.04万
• 依托单位: FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-04-01 至 2011-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8167261
• 关键词: Aggressive behavior; Behavior Therapy; Child; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Institution; Longevity; Pharmaceutical Preparations; Randomized Controlled Trials; Research; Research Personnel; Resources; Risperidone; Source; United States National Institutes of Health; Valproic Acid; experience; response; valproate

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This project compares, via a multisite randomized controlled trial with double-dummy medication administration, the efficacy, tolerability, and longevity of benefit of two agents, risperidone and valproate, in diminishing aggressive behavior when used adjunctively with stimulant treatment among children who experience demonstrably inadequate response to stimulant monotherapy and behavioral intervention.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 该项目通过一项多站点随机对照试验与两种药物给药，两种药物的功效，耐受性和益处的寿命，即利培酮和丙丙酸酯的益处，在与刺激治疗的刺激治疗辅助治疗时，对刺激性治疗的刺激性治疗的辅助性降低，对刺激性单独疗法的反应不足。